Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes. (2023)

First Author: Rajakumaraswamy N
Attributed to:  Biology and Treatment of Human Myeloid Cancers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.clml.2023.12.008

PubMed Identifier: 38216397

Publication URI: http://europepmc.org/abstract/MED/38216397

Type: Journal Article/Review

Parent Publication: Clinical lymphoma, myeloma & leukemia

ISSN: 2152-2669